Publicacións en colaboración con investigadores/as de University of Alabama at Birmingham (1)

2022

  1. Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)

    BMJ Open, Vol. 12, Núm. 1